Trial intelligence / Profile preview

Modified PHITT Strategy for Newly Diagnosed Hepatoblastoma

NCT04478292Phase 3Recruiting

Start
Mar 2021
Primary completion
Mar 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sodium thiosulfate in hepatoblastoma. Started Mar 2021; status: recruiting.

02

Drugs

sodium thiosulfate
03

Conditions

hepatoblastoma

Beyond the preview

Go deeper on NCT04478292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04478292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call